tiprankstipranks
Trending News
More News >

Lee’s Pharmaceutical Schedules Board Meeting to Approve Annual Results

Story Highlights
Lee’s Pharmaceutical Schedules Board Meeting to Approve Annual Results

Don’t Miss TipRanks’ Half-Year Sale

An update from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.

Lee’s Pharmaceutical Holdings Limited has announced a board meeting scheduled for March 27, 2025, to discuss the approval of the company’s annual results for the year ending December 31, 2024, and to consider recommending a final dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential returns for investors.

More about Lee’s Pharmaceutical Holdings Limited

Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. It focuses on developing, manufacturing, and marketing pharmaceutical products, with a market presence in Hong Kong.

YTD Price Performance: -10.56%

Average Trading Volume: 192,532

Technical Sentiment Consensus Rating: Hold

Current Market Cap: HK$747.8M

For detailed information about 0950 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1